ROIV

NASDAQ

Roivant Sciences Ltd. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$20.80B

PE Ratio

—

EV to Ebitda

—

Earnings Yield

-4.10%

Revenue (TTM)

$13.3M

Net Income (TTM)

$-1.01B

Revenue (Annual YoY Growth)

-11.19%

Revenue (Quarterly YoY Growth)

-77.83%

Profit Margin

-7558.42%

Return on Equity

-19.87%

Debt to Equity Ratio

0.0255

Dividend Yield

0.00%

All fundamentals

Core9 fields›

Market Cap$20.80B

Revenue TTM$13.3M

Shares Outstanding715.7M

Float551480710

Float Short4.66%

Days To Cover4.6726575254

Short Interest24878599.0

Relative Strength82.8

GARP3790

Growth Estimates15 fields›

Revenue Growth (Annual)-11.19%

Revenue Growth (Quarterly YoY)-77.83%

Operating Revenue Growth (Annual)-0.155627

Operating Revenue Growth (Quarterly YoY)-0.193028

3-Year Revenue Growth-19.30%

5-Year Revenue Growth-15.56%

EPS Growth (Annual)-104.53%

EPS Growth (Quarterly YoY)-262.80%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate0.00%

LT EPS Growth Estimates-32.50%

EBITDA Growth (Annual)-35.86%

EBITDA Growth (Quarterly YoY)-24.23%

CFO Growth (Annual)-9.69%

CFO Growth (Quarterly YoY)5.20%

Operations28 fields›

Revenue TTM$13.3M

Gross Margin TTM60.46%

Gross Margin (Quarterly)30.42%

R&D % of Revenue TTM4715.70%

R&D Expenses TTM$627.7M

Operating Margin TTM-9130.53%

Operating Margin (Quarterly)-16966.13%

Operating Expenses TTM$1.22B

Profit Margin TTM-7558.42%

Profit Margin (Quarterly)-15692.90%

Net Income TTM$-1.01B

EPS TTM-1.1685

EPS (Quarterly)-0.3816

EBIT Margin TTM-9130.53%

EBIT Margin (Quarterly)-16966.13%

EBITDA Margin TTM-9099.77%

EBITDA Margin (Quarterly)-16931.57%

EBITDA TTM$-1.21B

CFO % of Revenue TTM-2889.38%

CFO % of Revenue (Quarterly)-9829.11%

CFO TTM$-759.1M

Cash Margin-5703.52%

Capex % of Revenue TTM58.29%

Capital Expenditures$7.8M

FCF % of Revenue TTM-2905.21%

FCF % of Revenue (Quarterly)-9582.24%

FCF TTM$-766.9M

Fundamental Score4

Efficiency6 fields›

ROE-19.87%

ROA-18.95%

ROIC-19.48%

CROCI-14.85%

Stock Comp % (Quarterly)5252.48%

Stock Comp % TTM994.83%

Valuation13 fields›

P/S Forward309.4197

PEG-0.0346

EV/EBITDA Forward-13.4704

EV/Revenues (TTM)1254.7163

EV/Revenues Forward253.0685

EV/CFO-15.3888

EV/FCF (TTM)-21.7776

Price To Book4.7828

Price to Tangible Book1.3725

Earnings Yield-4.10%

FCF Yield-3.89%

Dividend Yield0.00%

Value Score1

Relative to Industry5 fields›

Relative Gross Margin (Quarterly)0.3897

Relative P/S241.577

Relative P/B1.0717

Relative Dividend Yield0

Relative Debt to Equity0.0747

Liquidity14 fields›

Cash Per Share6.3867

Current Ratio30.6644

Cash & ST Assets$4.53B

Total Debt$98.5M

Goodwill & Intangibles$0.00M

Total Assets$5.23B

Total Liabilities$251.1M

Shareholders Equity$4.27B

Debt to Equity0.0255

Debt to Assets2.08%

Interest Expense$0.00M

CFO to Debt (TTM)-7.472

Debt to EBITDA (TTM)-0.0839

Goodwill % of Assets0.00%

Yields4 fields›

Dividend Yield0.00%

Earnings Yield-4.10%

Buyback Yield-0.17%

Shareholder Yield-0.29%

Options Flow8 fields›

Call Volume58

Put Volume19

Put/Call Ratio0.3275862068965517

Call $ Volume27399

Put $ Volume2165

Put/Call $ Ratio0.07901748238986825

Call OI28714

Put OI16680